Effect of gender on the outcomes of contemporary percutaneous coronary intervention

American Journal of Cardiology

Volumn 88, Issue 4, 2001, Pages 359-364

  Peterson, Eric D ^a,d   Lansky, Alexandra J ^b   Kramer, Judith ^a   Anstrom, Kevin ^a   Lanzilotta, Michael J ^c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c National Healthcare Network   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHERECTOMY; BODY SURFACE; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICE; FEMALE; GENDER; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; STATISTICS; STROKE; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY, CORONARY; BODY SURFACE AREA; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RISK FACTORS; SEX FACTORS; STENTS;

EID: 0035880738     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01679-4     Document Type: Article

References (23)

1. Do PTCA mortality outcomes need to be risk-adjusted? Results from the National Cardiovascular Network (NCN)
2. Identification of variables needed to risk adjust outcomes of coronary interventions: Evidence-based guidelines for efficient data collection
3. Results of percutaneous transluminal coronary angioplasty in women 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry
4. Percutaneous transluminal coronary angioplasty in women compared with men
5. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty. A regional prospective study of 13,061 procedures
6. Causes and correlates of death after unsupported coronary angioplasty: Implications for use of angioplasty and advanced support techniques in high-risk settings
7. Comparative safety and efficacy of percutaneous transluminal coronary angioplasty in men and in women
8. Gender differences for coronary angioplasty
9. The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty
10. Long-term outcome of women compared with men after successful coronary angioplasty
11. Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the new approaches to coronary intervention (NACI) registry
12. Comparison of procedural results and risks of coronary angioplasty in men and women for conditions other than acute myocardial infarction
13. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery
14. Sex differences in coronary artery size assessed by intravascular ultrasound
15. Comparison of men and women in cross sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris
16. Higher mortality in women following angioplasty explained by differences in body size, not vessel size
17. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome
18. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
19. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
20. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
21. One-year follow-up in the coronary angioplasty versus excisional atherectomy trial (CAVEAT-1)
22. Final results of the Balloon vs Optimal Atherectomy Trial (BOAT)
23. Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide